EP3154581
BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.6.2015EP published:
20.2.2019EP application number:
15747597.1
EPO information:
European Patent Register
Max expiry date:
14.6.2035
Title:
BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS
Timeline
Today
15.6.2015EP application
20.2.2019EP Publication
Owner
Name:
The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicesAddress:
National Institutes of Health Office of Technology Transfer 6011 Executive Boulevard Suite 325 MSC 7660, 20852-7660, Bethesda, MD, US
Name:
Janssen Biotech, Inc.Address:
1400 Mckean Road, 19477, Spring House, PA, US
Inventor
Name:
CHILDS, Richard, W.Address:
Bethesda, MD, US
Name:
BERG, MariaAddress:
Bethesda, MD, US
Name:
CALDERON, Luis, EspinozaAddress:
Bethesda, MD, US
Name:
SASSER, KateAddress:
Spring House, PA, US
Name:
ATTAR, RicardoAddress:
Spring House, PA, US
Priority
Number:
201462012864 PDate:
16.6.2014Country:
US
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00, A61P 37/00